Primary |
Osteoporosis |
62.2% |
Osteopenia |
19.6% |
Osteoporosis Prophylaxis |
4.9% |
Bone Density Decreased |
1.8% |
Rheumatoid Arthritis |
1.8% |
Osteoporosis Postmenopausal |
1.8% |
Bone Disorder |
1.3% |
Drug Use For Unknown Indication |
1.2% |
Resorption Bone Increased |
0.9% |
Hypertension |
0.7% |
Back Pain |
0.6% |
Osteoarthritis |
0.5% |
Osteitis Deformans |
0.5% |
Prophylaxis |
0.5% |
Bone Density Abnormal |
0.4% |
Pain |
0.3% |
Metastases To Bone |
0.3% |
Prostate Cancer |
0.3% |
Atrial Fibrillation |
0.3% |
Arthritis |
0.2% |
|
Pain In Extremity |
10.6% |
Vomiting |
9.7% |
Stress Fracture |
8.7% |
Myalgia |
7.6% |
Pain |
7.5% |
Pyrexia |
6.4% |
Femur Fracture |
6.2% |
Toothache |
6.0% |
Weight Decreased |
4.6% |
Osteonecrosis |
4.1% |
Pain In Jaw |
4.1% |
Tooth Extraction |
4.1% |
Nausea |
2.8% |
Pathological Fracture |
2.8% |
Fall |
2.7% |
Tooth Disorder |
2.6% |
Vision Blurred |
2.6% |
Arthralgia |
2.3% |
Tooth Fracture |
2.3% |
Tooth Loss |
2.3% |
|
Secondary |
Osteoporosis |
46.2% |
Osteopenia |
23.2% |
Rheumatoid Arthritis |
5.9% |
Product Used For Unknown Indication |
4.4% |
Hypertension |
3.3% |
Osteoporosis Prophylaxis |
3.2% |
Drug Use For Unknown Indication |
2.1% |
Hormone Replacement Therapy |
1.4% |
Pain |
1.3% |
Depression |
1.2% |
Hypothyroidism |
1.2% |
Non-small Cell Lung Cancer |
1.2% |
Prophylaxis |
0.8% |
Asthma |
0.8% |
Anxiety |
0.7% |
Arthritis |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
Blood Cholesterol Increased |
0.6% |
Colitis Ulcerative |
0.5% |
Osteitis Deformans |
0.5% |
|
Femur Fracture |
16.3% |
Low Turnover Osteopathy |
11.9% |
Weight Decreased |
7.2% |
Stress Fracture |
5.0% |
Tooth Disorder |
4.4% |
Osteonecrosis |
4.3% |
Osteonecrosis Of Jaw |
4.2% |
Vomiting |
4.2% |
Urinary Tract Infection |
4.1% |
Vertigo |
4.1% |
Vitamin D Deficiency |
4.1% |
Weight Increased |
4.1% |
Drug Ineffective |
3.9% |
Tooth Fracture |
3.9% |
Fall |
3.5% |
Pain |
3.5% |
Anxiety |
3.1% |
Tooth Extraction |
3.1% |
Wrist Fracture |
2.9% |
Pain In Extremity |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
19.2% |
Drug Use For Unknown Indication |
18.6% |
Rheumatoid Arthritis |
17.5% |
Osteoporosis |
12.3% |
Hypertension |
6.4% |
Prophylaxis |
3.0% |
Pain |
2.6% |
Crohn's Disease |
2.1% |
Depression |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Blood Cholesterol Increased |
1.8% |
Asthma |
1.8% |
Diabetes Mellitus |
1.5% |
Osteopenia |
1.4% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Breast Cancer |
1.3% |
Anxiety |
1.2% |
Atrial Fibrillation |
1.2% |
Multiple Sclerosis |
1.2% |
Hypothyroidism |
1.1% |
|
Vomiting |
15.1% |
Weight Decreased |
12.6% |
Weight Increased |
8.7% |
Pneumonia |
5.8% |
Urinary Tract Infection |
5.8% |
Nausea |
5.4% |
Rash |
4.2% |
Pain |
4.1% |
Drug Ineffective |
3.9% |
Death |
3.4% |
Myocardial Infarction |
3.4% |
Urticaria |
3.4% |
Pain In Extremity |
3.3% |
Rheumatoid Arthritis |
3.2% |
Pyrexia |
3.2% |
Tremor |
2.9% |
Diarrhoea |
2.8% |
Sepsis |
2.8% |
Vision Blurred |
2.8% |
Pruritus |
2.8% |
|
Interacting |
Drug Use For Unknown Indication |
17.9% |
Hypertension |
10.3% |
Pain |
9.0% |
Coronary Artery Disease |
7.7% |
Type 2 Diabetes Mellitus |
6.4% |
Dyslipidaemia |
5.1% |
Osteoporosis |
5.1% |
Prophylaxis Against Gastrointestinal Ulcer |
5.1% |
Restless Legs Syndrome |
5.1% |
Hyperparathyroidism Secondary |
3.8% |
Nausea |
3.8% |
Renal Failure |
3.8% |
Vitamin Supplementation |
3.8% |
Back Pain |
2.6% |
Rheumatoid Arthritis |
2.6% |
Smoking Cessation Therapy |
2.6% |
Anxiety |
1.3% |
Bone Disorder |
1.3% |
Depression |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
|
Transaminases Increased |
55.6% |
Nephrolithiasis |
22.2% |
Drug Interaction |
11.1% |
Panic Attack |
11.1% |
|